Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St. John's Wort and Docetaxel in Solid Tumors
NCT00041171Phase 3Withdrawn
- Sponsor
- Cancer and Leukemia Group B
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of docetaxel in solid tumor, sponsored by Cancer and Leukemia Group B. Status: withdrawn.
02
Drugs
docetaxel
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00041171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041171.